February 25, 2009

HANDOK Pharm secures a momentum to tap health supplement market

OptimaCare will provide HANDOK Pharm’s OTC drugs through its pharmacy chains

HANDOK Pharmaceuticals Co. Ltd. announced it has signed an agreement with OptimaCare Co. Ltd. to cooperate on the development and marketing of healthcare supplements and over-the-counter products.

With the agreement, HANDOK Pharmaceuticals will introduce healthcare supplements from OptimaCare to advance into a new market, while OptimaCare will deal with HANDOK Pharm’s OTC products across its distribution pharmacy channels.

“I am very pleased to have started ways to advance into the healthcare supplement market in hands with OptimaCare to be closer to consumers and HANDOK Pharm’s brand awareness,” said Young-jin Kim, chairman and CEO of HANDOK Pharmaceuticals. “Marketing expertise combined with OptimaCare’s infrastructure will create synergies that will further improve the nation’s health in line with changing market demand.”

“It is vital to provide reliable healthcare supplement as they are a must to modern men and OptimaCare will continue efforts to develop quality products based on scientific findings to build consumer confidence and we will provide our accumulated know-how to help position OptimaCare products as to represent one of HANDOK Pharm’s major brands,” said Jae-hyun Kim, president of OptimaCare.

The pharmacy chain OptimaCare is committed to promoting the nation’s health by preventing and managing diseases. OptimaCare’s products use enzymes, organic and natural ingredients to minimize side effects, challenging therapeutic areas beyond disease prevention. It aims to achieve a 2,000 franchisee mark and 3,000 member pharmacies under an academic society within this year.